Psychiatric_Study_Guide_2025_2026
1. An adjustment disor- major depression or generalized anxiety disorder (GAD).
der that persists and
worsens can potential-
ly evolve into other psy-
chiatric disorder such as
2. Maladaptive behavior adjustment disorder, with the major symptom speci�ed (eg, "adjust-
in response to stress is ment disorder with depressed mood"
called
3. PTSD is classi�ed as Trauma and stressor - not anxiety
what type of disorder in
the DSM-5
4. The key to establishing in the history of exposure to a life-threatening event followed by intru-
the diagnosis of PTSD sive (eg, ashbacks, nightmares) or avoidance (eg, withdrawal) symp-
lies toms. DSM-5 includes the requirement that the symptoms persist for at
least 1 month.
5. Patients with PTSD ex- physiologic hyperarousal, including startle reactions, intrusive thoughts,
perience illusions, overgeneralized associations, sleep problems, nightmares,
dreams about the precipitating event, impulsivity, di culties in concen-
tration, and hyperalertness.
6. Di erential Dx of PTSD comorbid depression, panic disorder, acute stress disorder, borderline
personality disorder
7. Acute stress disorder but lasts between 2 and 28 days.
occurs during or short-
ly after a traumatic
event and has many of
the same symptoms as
PTSD
,8. What is considered Sertraline and paroxetine are approved by the US Food and Drug
the pharmacotherapy Administration (FDA) for this purpose, and the SSRIs are the only class
of choice for PTSD? of medications approved
9. What are the symptoms Apprehension, worry, irritability, di culty in concentrating, insomnia,
of generalized anxiety and somatic complaints are PRESENT MORE DAYS THAN NOT FOR AT
disorder (GAD)? LEAST 6 MONTHS.
Manifestations can include cardiac, gastrointestinal, and neurologic
10. _________________________- PANIC DISORDER
is characterized by
recurrent,
unpredictable episodes
of intense anxiety
accompanied by
marked physiologic
manifestations
11. What is the drug of benzodiazepines are the anxiolytics of choice in the acute management
choice for managing of generalized anxiety
ACUTE generalized anx-
iety disorder?
12. What are the FDA ap- Venlafaxine and duloxetine are FDA-approved for the treatment of GAD
proved treatments for in usual antidepressant doses. Initial daily dosing should start low
GAD (37.5-75 mg for venlafaxine and 30 mg for duloxetine) and be titrated
upward as needed. SSRIs, such as paroxetine, are also used.
13. ______________has no Bupropion (pg.
clear usefulness in the
treatment of anxiety
disorders.
, 14. SSRIs, that are ap- uoxetine, paroxetine, and sertraline
proved for the treat-
ment of panic disorder.
15. The SNRI that is FDA ap- venlafaxine
proved for treatment of
panic disorder.
16. OD of benzo's are Overdosage results in respiratory depression, hypotension, shock syn-
drome, coma, and death
17. What are the side ef- sedation & disinhibition, ataxia, dysarthria, nystagmus, and delirium.
fects of high dose ben-
zodiazepines?
18. Reversal of benzo OD Flumazenil
(benzodiazepine antag-
onist)
19. Classi�cation of somatic , psychological & perceptual
low-mod benzo use
20. Panic disorder drug of SSRIs sertraline, paroxetine, and uoxetine. In addition, the SNRI ven-
choice lafaxine is approved by the FDA
21. Phobic disorder tx SSRIs & SNRIs
22. Both GAD, panic disor- cognitive behavioral
der & phobias appear
to respond as well to
________________ therapy
as they do to medica-
tions.